AUFA, Syafiq; ISMY, Jufriady. Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer. Indonesian Journal of Global Health Research, [S. l.], v. 8, n. 6, p. 89–98, 2026. DOI: 10.37287/ijghr.v8i6.2572. Disponível em: https://jurnal2.globalhealthsciencegroup.com/index.php/IJGHR/article/view/2572. Acesso em: 4 sep. 2026.